Hematological disorders in children with Down syndrome

Triarico, Silvia; Trombatore, Giovanna; Capozza, Michele Antonio; Romano, Alberto; Attinà, Giorgio; Maurizi, Palma; Ruggiero, Antonio

doi:10.1080/17474086.2022.2044780

Cited by 1 publication

(1 citation statement)

References 95 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The differential diagnosis includes vasculitis, drug exanthem, neutrophilic dermatosis, infection, or urticaria, among others [8]. Patients with trisomy 21 have an importantly unique ddx including transient abnormal myelopoiesis vs. myeloproliferative disorder vs. AML/ALL with consideration of the 10–20-fold increase in risk of acute leukemia in this population [9 ▪▪ ]. A recent case series on dermoscopic characterization of adult LC lesions found most (4/5) cases had lesions with a polymorphic vascular patterns [7 ▪ ].…”

Section: Leukemia Cutismentioning

confidence: 99%

Pearls and updates: cutaneous signs of systemic malignancy

Paquette

Cotter

Huang

2022

Current Opinion in Pediatrics

View full text Add to dashboard Cite

Purpose of reviewChildren with systemic malignancies can present with concomitant dermatological manifestations. Cutaneous findings can occur before, during or after diagnosis. Recognizing these features can aid in diagnosis, inform prognosis, and help determine appropriate treatment. Following a review of the literature published over the past two years, we provide an update on cutaneous signs of pediatric systemic malignancies, concentrating on; leukemia cutis, lymphoma cutis, neuroblastoma, sarcomas, Langerhans cell histiocytosis and paraneoplastic syndromes. Recent findingsAuthors highlight the persistently heterogeneous features of cutaneous manifestations of systemic malignancy. Findings are often nonspecific, and a definitive diagnosis requires skin biopsy with immunophenotyping. Several studies describe dermoscopy features, demonstrating this as a useful tool in clinical evaluation. Genetic mutations underlying the pathogenesis of disease continue to be elucidated. Further, advances in medical treatment led to improved prognosis in many systemic malignancies, with early and aggressive treatment heralding better outcomes. SummaryComprehensive cutaneous evaluation alongside thorough clinical history and review of systems remains of paramount importance as dermatological manifestations of systemic malignancy are notoriously variable with a shared feature of often appearing benign but persisting despite usual treatment. Urgent referral to dermatology is recommended when suspicion for any cutaneous presentation of malignancy arises.

show abstract

Section: Leukemia Cutismentioning

confidence: 99%